Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers. (Q42492498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Min Yao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Elaine Yu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Fang Fan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Nikki Cheng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

1 reference

29 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

810-823

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125354%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2016.78

3 April 2020

exact match

0 references

cites work

Global cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

The molecular pathology of breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Overcoming treatment challenges in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Treatment of metastatic breast cancer: looking towards the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Improvement of survival and prospect of cure in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Tailoring adjuvant treatments for the individual patient with luminal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Fibrosis as in indication of time in infiltrating breast cancer and its importance in prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Identification and characterization of a fibroblast marker: FSP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Regulation of in situ to invasive breast carcinoma transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Management of inflammatory breast cancer after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Molecular characterization of the tumor microenvironment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

The chemokine system and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Factors affecting survival among women with breast cancer in Hawaii

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Time to Surgery and Breast Cancer Survival in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Timeliness in Breast Cancer Treatment-The Sooner, the Better

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Translating the concept of intrinsic subtypes into an oncoplastic cohort of more than 1000 patients - predictors of recurrence and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Human breast cancer cells educate macrophages toward the M2 activation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.78

Distribution of macrophage polarization markers in human atherosclerosis

21 January 2018

1 reference

12 December 2020

[Prognostic significance of desmoplasia in breast carcinoma. A preliminary clinical study]

1 reference

12 December 2020

Undertreatment of obese women receiving breast cancer chemotherapy

1 reference

12 December 2020

Cox models survival analysis based on breast cancer treatments.

1 reference

12 December 2020

Triple-negative breast cancer: an unmet medical need

1 reference

12 December 2020

Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients

1 reference

12 December 2020

Who should not receive chemotherapy? Data from American databases and trials

1 reference

12 December 2020

Identification of fibroblast heterogeneity in the tumor microenvironment

1 reference

12 December 2020

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer

1 reference

12 December 2020